Research Paper Volume 15, Issue 18 pp 9561—9571
Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis
Figure 3. Forest plot displaying hazard ratios for comparing progression-free survival between immuno-chemotherapy and chemotherapy. (A) Patients with liver metastases. (B) Patients without liver metastases.